Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACLATASVIR vs DACTINOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DACLATASVIR vs DACTINOMYCIN: Safety Overview

Metric DACLATASVIR DACTINOMYCIN
Total FAERS Reports 5,602 2,858
Deaths Reported 581 507
Death Rate 10.4% 17.7%
Hospitalizations 1,637 721
Average Patient Age 58.1 yrs 18.8 yrs
% Female Patients 39.7% 65.9%
FDA Approval Date Apr 13, 2016 Approved Prior to Jan 1, 1982
Manufacturer N/A Eugia US LLC
Route N/A INTRAVENOUS
Marketing Status Discontinued Discontinued